REPRO-MED SYSTEMS, INC. Chart calendar Repro-Med Systems, Inc.
2a1e7ef.RiJw1IPS_srsqW3_4fBQTMTLlw68klrQx4mv02lmSbk.BGQfve6BpomD3FSTuKZlA4is5Trf3Qziq-Pqq0Q3AuB0SBaZy7yfrtSaKA~6b90a65dbd6c33ce80de3e1618a10e02
Upcoming events on Repro-Med Systems, Inc.
Past events on Repro-Med Systems, Inc.
| 2024-03-13 04:30 pm | Q4 2023 Earnings Call |
| 2024-03-13 04:05 pm | Q4 2023 Earnings Release |
| 2023-12-05 10:00 am | Investor Day |
| 2023-11-29 01:30 pm | Piper Sandler Healthcare Conference |
| 2023-11-15 | Craig-Hallum Alpha Select Conference |
| 2023-11-15 | Canaccord Genuity MedTech Diagnostics and Digital Health and Services Forum |
| 2023-11-08 04:30 pm | Q3 2023 Earnings Call |
| 2023-11-08 04:05 pm | Q3 2023 Earnings Release |
| 2023-10-04 | Immunoglobulin National Society National Conference |
| 2023-09-21 02:00 pm | Gilmartin Group Emerging Growth Company Showcase |
| 2023-08-10 01:00 pm | Canaccord Genuity Growth Conference |
| 2023-08-09 04:30 pm | Q2 2023 Earnings Call |
| 2023-08-09 04:01 pm | Q2 2023 Earnings Release |
| 2023-05-17 08:00 am | Annual General Meeting |
| 2023-05-04 04:30 pm | Q1 2023 Earnings Call |
| 2023-05-04 04:01 pm | Q1 2023 Earnings Release |
| 2023-03-08 04:30 pm | Q4 2022 Earnings Call |
| 2023-03-08 04:01 pm | Q4 2022 Earnings Release |
| 2022-12-01 03:00 pm | Piper Sandler Healthcare Conference |
| 2022-11-17 11:30 am | Canaccord Genuity CG MedTech, Diagnostics and Digital Health & Services Forum |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 23,2 22,3 3.71% | 24,2 24,8 -2.49% | 23,5 23,1 1.85% | 27,9 27,9 -0.07% | 28,5 28,3 0.92% | 31,6 |
|
EBITDA Million USD | Released Forecast Spread | 5,61 5,63 -0.21% | 3,66 3,63 0.8% | -1,78 -3,04 41.52% | -6,10 -6,77 10.02% | -6,03 -7,34 17.82% | -3,51 |
|
EBIT Million USD | Released Forecast Spread | 0,59 0,50 17.14% | 1,61 1,89 -15.03% | -5,60 -6,46 13.29% | -10,8 -11,3 4.44% | -10,3 -10,2 -0.98% | -7,33 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,70 1,48 -52.85% | -1,19 -0,27 -337.99% | -6,36 -6,56 3.05% | -10,7 -11,2 5.05% | -9,77 -9,91 1.36% | -6,98 |
|
Net income Million USD | Released Forecast Spread | 0,56 1,23 -53.99% | -1,21 -0,54 -124.32% | -4,56 -4,98 8.33% | -8,66 -9,22 6.08% | -13,7 -8,22 -67.14% | -6,19 |
|
EPS USD | Released Forecast Spread | 0,01 0,02 -50% | -0,03 -0,01 -125.06% | -0,10 -0,11 11.76% | -0,19 -0,21 8.07% | -0,30 -0,18 -66.67% | -0,14 |
| Announcement Date | 25/02/20 | 23/03/21 | 02/03/22 | 08/03/23 | 13/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 6,49 6,06 7.03% | 6,24 6,07 2.89% | 6,55 6,29 4.15% | 7,76 6,77 14.55% | 7,34 7,38 -0.48% | 7,39 7,56 -2.27% | 6,94 7,22 -3.98% | 7,00 7,93 -11.7% | 7,19 6,94 3.48% | 7,53 | 7,63 | 8,05 | 8,45 | 9,06 |
|
EBITDA Million USD | Released Forecast Spread | -0,59 -1,85 68.28% | -1,85 -1,43 -29.82% | -2,37 -2,58 8.11% | -0,38 -2,23 83.14% | -1,55 -2,18 28.72% | -1,97 -2,14 8.01% | -2,21 -2,43 9.19% | -0,89 -1,86 52.23% | -0,96 -1,68 42.66% | -0,98 | -1,07 | -0,91 | -0,54 | -0,10 |
|
EBIT Million USD | Released Forecast Spread | -2,11 -1,66 -26.93% | -2,79 -3,02 7.56% | -3,29 -3,67 10.3% | -1,53 -2,98 48.62% | -2,51 -3,00 16.33% | -3,01 -2,69 -11.94% | -3,22 -3,01 -6.85% | -1,79 -2,59 30.74% | -2,20 -2,29 3.91% | -1,89 | -1,99 | -1,91 | -1,55 | -1,48 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -1,44 -1,65 12.3% | -3,14 -3,01 -4.32% | -3,63 -3,65 0.61% | -1,50 -2,96 49.43% | -2,41 -2,99 19.22% | -2,99 -2,69 -11.21% | -3,10 -3,01 -2.78% | -1,67 -2,53 33.95% | -2,02 -2,21 8.43% | -1,81 | -1,89 | -1,81 | -1,48 | -1,43 |
|
Net income Million USD | Released Forecast Spread | -1,07 -1,48 27.67% | -2,54 -2,53 -0.48% | -2,92 -3,13 6.65% | -1,23 -2,53 51.55% | -1,98 -2,55 22.48% | -2,41 -2,32 -4.05% | -2,50 -2,60 3.83% | -1,37 -2,33 41.23% | -7,47 -1,93 -287.2% | -1,61 | -1,68 | -1,61 | -1,30 | -1,14 |
|
EPS USD | Released Forecast Spread | -0,02 -0,03 39.99% | -0,06 -0,06 -5.88% | -0,07 -0,07 0% | -0,03 -0,05 43.75% | -0,04 -0,06 29.42% | -0,05 -0,05 0% | -0,05 -0,06 11.77% | -0,03 -0,05 40% | -0,16 -0,04 -326.67% | -0,04 | -0,04 | -0,04 | -0,03 | -0,02 |
| Announcement Date | 02/03/22 | 04/05/22 | 03/08/22 | 09/11/22 | 08/03/23 | 04/05/23 | 09/08/23 | 08/11/23 | 13/03/24 | - | - | - | - | - |
| Today 04:05 pm | SILK ROAD MEDICAL, INC: Q1 2024 Earnings Release |
| Today 04:05 pm | MERIT MEDICAL SYSTEMS, INC.: Q1 2024 Earnings Release |
| 2024-04-30 | REPLIGEN CORPORATION: Q1 2024 Earnings Release |
| 2024-04-30 | BAUSCH + LOMB CORPORATION: Q1 2024 Earnings Release |
| 2024-04-30 | PROCEPT BIOROBOTICS CORPORATION: Q1 2024 Earnings Release |
| 2024-05-01 06:00 am | LIVANOVA PLC: Q1 2024 Earnings Release |
| 2024-05-01 06:30 am | CENCORA, INC.: Q2 2024 Earnings Release |
| 2024-05-01 04:01 pm | ATRICURE, INC.: Q1 2024 Earnings Release |
| 2024-05-01 04:10 pm | ENVISTA HOLDINGS CORPORATION: Q1 2024 Earnings Release |
| 2024-05-01 | TANDEM DIABETES CARE, INC.: Q1 2024 Earnings Release |
